Skip to main content
Asia Green Biotechnology Corp. logo

Asia Green Biotechnology Corp. — Investor Relations & Filings

Ticker · ASIA CSE Agriculture, forestry and fishing
Open in API
Filings indexed 102 across all filing types
Latest filing 2024-11-28 Management Reports
Country CA Canada
Listing CSE ASIA

About Asia Green Biotechnology Corp.

https://asiagreenbiotechnology.com

Asia Green Biotechnology Corp. is an early-stage international agri-technology company specializing in the development, evaluation, testing, application, and supply of agricultural products. The core business involves the cultivation and harvesting of hemp crops for both industrial and pharmacological applications. The company manufactures pharmaceutical products derived from these crops and is actively engaged in clinical studies, including research focused on migraine treatment.

Recent filings

Filing Released Lang Actions
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is clearly titled “Management’s Discussion and Analysis for the three and nine months ended September 30, 2024 and 2023,” prepared under IAS 34 Interim Financial Reporting. It provides management’s narrative on quarterly financial results, risks, forward-looking statements, and selected Q3 financial data—exactly matching the definition of Management Reports (MD&A). This is not a brief announcement or an investor presentation but the full MD&A section of an interim filing.
2024-11-28 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 “Venture Issuer Basic Certificate,” signed by the CEO certifying the interim financial report and MD&A for the period ended September 30, 2024. It does not itself contain financial statements or MD&A, but is a regulatory certification form filed alongside the interim report. It is brief and does not present the interim results, nor does it announce the availability of a report—it is a statutory certificate. There is no specific category for certification forms, so it falls into the fallback “Regulatory Filings” category (RNS).
2024-11-28 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 “Certification of Interim Filings” under Canadian NI 52-109, signed by the CFO, certifying that the interim financial report and MD&A for the period ended September 30, 2024 comply with disclosure requirements. It is a regulatory certificate filed alongside interim financial statements rather than the interim report itself. This does not present financial results but constitutes a regulatory filing form; thus it falls under the catch-all category “Regulatory Filings” (RNS).
2024-11-28 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Condensed Interim Financial Statements' for the three and nine months ended September 30, 2024. It contains comprehensive financial statements (Statement of Financial Position, Statement of Loss and Comprehensive Loss, Statement of Changes in Shareholders' Deficit, and Statement of Cash Flows) along with detailed notes to the financial statements. It is not an announcement of a report, but the report itself, and it contains substantive financial data, fitting the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-28 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2024-08-26 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2024-08-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.